Verde Bio Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Scott Cox
Chief executive officer
US$225.0k
Total compensation
| CEO salary percentage | 82.2% |
| CEO tenure | 4.5yrs |
| CEO ownership | 1.7% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jan 31 2024 | n/a | n/a | -US$3m |
| Oct 31 2023 | n/a | n/a | -US$2m |
| Jul 31 2023 | n/a | n/a | -US$1m |
| Apr 30 2023 | US$225k | US$185k | -US$2m |
| Jan 31 2023 | n/a | n/a | -US$2m |
| Oct 31 2022 | n/a | n/a | -US$2m |
| Jul 31 2022 | n/a | n/a | -US$4m |
| Apr 30 2022 | US$370k | US$180k | -US$3m |
| Jan 31 2022 | n/a | n/a | -US$6m |
| Oct 31 2021 | n/a | n/a | -US$5m |
| Jul 31 2021 | n/a | n/a | -US$3m |
| Apr 30 2021 | US$284k | US$30k | -US$3m |
Compensation vs Market: Scott's total compensation ($USD225.00K) is below average for companies of similar size in the US market ($USD663.07K).
Compensation vs Earnings: Scott's compensation has been consistent with company performance over the past year.
CEO
Scott Cox (51 yo)
4.5yrs
Tenure
US$225,000
Compensation
Mr. Scott A. Cox serves as Chief Executive Officer, Chief Financial Officer & Director at THC Therapeutics, Inc. He has been Senior Vice President of Corporate Development at NewBridge Global Ventures, Inc...